The level of soluble IL-2 receptor in adults with chronic rhinosinusitis
https://doi.org/10.17021/1992-6499-2025-4-51-57
Abstract
Chronic rhinosinusitis is one of the most common chronic human diseases. One of the markers of activation of immunological processes of interest is the soluble IL-2 receptor (sIL-2R). An increase in the concentration of sIL-2R accompanies many inflammatory diseases, including those involving immunopathological processes. The aim of the study was to study the local production of sIL-2R in elderly and senile people with chronic rhinosinusitis. Material and research methods. Of the patients included in the study (n = 147), 4 groups were formed. The content of sIL-2R in nasal secretions was assessed using an enzyme immunoassay kit (Multiscan Accent; FineTest reagents) according to the instructions. Research results. In general, the data obtained show that sIL-2R production in the nasal secretions of elderly people is significantly higher than in the elderly (Iu 13.2[10.2;13.4] pg/ml vs Me 43[35;46] pg/ml, p = 0.014). An analysis of age-related features in patients with chronic rhinosinusitis indicates that the level of the receptor in mature patients is comparable to that in the elderly and senile, respectively (Me 32.2[28;45.5] pg/ml vs Me 72.9[57.2;79] pg/ml vs Me 79[65;99] pg/ml) and demonstrates an increase in sIL-2R production with age. Conclusion. Senile age compared with the elderly is associated with higher production of sIL-2R in the nasal cavity. The inflammatory process during exacerbation of chronic rhinosinusitis is characterized by an increase in its production, but there is no difference in the indicator between elderly and senile patients.
About the Authors
E. B. BelanRussian Federation
Eleonora B. Belan, Dr. Sci. (Med.), Professor, Head of the Department,
Volgograd .
N. V. Tarasova
Russian Federation
Natalia V. Tarasova, Dr. Sci. (Med.), Professor, Head of the Department,
Volgograd.
M. V. Sokolova
Russian Federation
Maria V. Sokolova, Assistant of the Department,
Volgograd.
A. V. Gorshenin
Russian Federation
Andrey V. Gorshenin, Cand. Sci. (Med.), Head of the Laboratory,
Volgograd.
References
1. Ivanchenko O. A., Lopatin A. S. Chronic rhinosinusitis: epidemiology, classification, etiology, pathogenesis. A modern view of the problem. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2012; 77 (2): 91–96 (In Russ.).
2. Belan E. B., Chueva M. A., Sadchikova T. L. Clinical and immunological features of atopic dermatitis in children. Allergologiya i immunologiya v pediatrii = Allergology and immunology in pediatrics. 2022; 4 (71). URL: https://cyberleninka.ru/article/n/kliniko-immunologicheskie-osobennosti-atopicheskogo-dermatita-u-detey (In Russ.).
3. Samotrueva M. A., Yasenyavskaya A. L., Bashkina O. A., Myasoedov N. F., Andreeva L. A. Glyprolines as modulators of immunoreactivity within conditions of “social” stress. Farmatsiya i farmakologiya = Pharmacy and Pharmacology. 2019; 4. URL: https://cyberleninka.ru/article/n/glyprolines-as-modulators-of-immunoreactivity-withinconditions-of-social-stress (accessed: 26.01.2025).
4. Tataurshchikova N. S., Sidorovich I. G. Cytokine status as a criterion for the effectiveness of intranasal aerosol therapy with cycloferon solution in the treatment of allergic rhinosinusitis. Vestnik otorinolaringologii = Bulletin of otorhinolaryngology. 2012; 77 (3): 79–82 (In Russ.).
5. Damoiseaux J. The IL-2 – IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor. Clin Immunol. 2020 Sep; 218: 108515. doi: 10.1016/j.clim.2020.108515. PMID: 32619646.
6. Wang N., Schoos A. M., Larsen J. M., Brix S., Thysen A. H., Rasmussen M. A., Stokholm J., Bønnelykke K., Bisgaard H., Chawes B. L., Reduced IL-2 response from peripheral blood mononuclear cells exposed to bacteria at 6 months of age is associated with elevated total-IgE and allergic rhinitis during the first 7 years of life. BioMedicine. 2019 May; 43: 587–593. doi: 10.1016/j.ebiom.2019.04.047.
7. Utomo B. S. R., Hatta M., Sirait R. H., Pratiwi S. and Massi M. N., The Role of Cytokine Interleukin-2, Transcription Factor of FoxP3 in the Immunological Regulation of Allergic Rhinitis. International Journal of Otolaryngology and Head & Neck Surgery. 2018 Jan 07 (01): 7–19. doi: 10.4236/ijohns.2018.71002.
8. Mastraftsi S., Vrioni G., Bakakis, M., Nicolaidou E., Rigopoulos D., Stratigos A.J., Gregoriou S. Atopic Dermatitis: Striving for Reliable Biomarkers. J. Clin. Med. 2022 Aug 9; 11 (16): 4639. doi: 10.3390/jcm11164639.2619646.
9. International classification of functioning, disability, and health. Geneva: World Health Organization; 2001. URL: http://who-fic.ru/icf /.
10. Tsybikov N. N., Egorova E. V., Ivanov M. O., Fefelova E.V., Tsybikov N. B. Coagulating and fibrinolytic properties of nasal secretions in patients with chronic rhinosinusitis, ENI. Zabaykalskiy meditsinskiy vestnik = Zabaikalsky Medical Bulletin. 2018; 4 (In Russ.).
11. Wang N., Schoos A. M., Larsen J. M., Brix S., Thysen A. H., Rasmussen M. A., Stokholm J., Bønnelykke K., Bisgaard H., Chawes B. L. Reduced IL-2 response from peripheral blood mononuclear cells exposed to bacteria at 6 months of age is associ-ated with elevated total-IgE and allergic rhinitis during the first 7 years of life. EBioMedicine. 2019 May; 43: 587–593. doi: 10.1016/j.ebiom.2019.04.047. PMID: 31056472; PMCID: PMC6558232.
12. Fontenot J. D., Rasmussen J. P., Gavin M. A., Rudensky A. Y. A function for interleukin 2 in Foxp3expressing regulatory T cells. Nat Immunol. 2005 Nov; 6 (11): 1142–1151. doi: 10.1038/ni1263. PMID: 16227984.
13. Dik W. A., Heron M. Clinical significance of soluble interleukin-2 receptor measurement in immunemediated diseases. Neth J Med. 2020 Sep; 78 (5): 220–231. PMID: 33093245.
14. Oportus J., Hojman L., Gonzalez V., Karsulovic C. Soluble IL-2R as a Marker of T Cell Activation in Immune-Mediated Diseases: Review and Case-Based Interpretation. Lymphatics. 2025; 3 (1). doi: 10.3390/lymphatics3010001.
15. Ivanchenko O. A., Karpenko S. A., Sopko O. N., Kozlov R. S., Krechikova O. I., Bravagin I. V., Pishkunov G. Z., Lopat A. S. Microbiome of the maxillary sinus and the middle nasal passage in chronic rhinosinusitis. Rinologiya = Rhinology. 2019; 54: 68–74. doi: 10.4193/Rhin15.018.
16. Artemenkov A. A. Age-dependent dysregulation of the immune response in humans. Meditsinskaya immunologiya = Medical immunology. 2021; 5. URL: https://cyberleninka.ru/article/n/vozrast-zavisimayadisregulyatsiya-immunnogo-otveta-u-cheloveka (In Russ.).
17. Tarasova N. V., Belan E. B., Stepanenko I. S., Sokolova M. V. Microbial colonization of the nasal mucosa in elderly people with chronic rhinosinusitis. Saratovskiy nauchno-meditsinskiy zhurnal = Saratov Scientific and Medical Journal. 2024; 20 (2): 121–126. doi: 10.15275/ssmj2002121 EDN: XNRSOA (In Russ.).
Review
For citations:
Belan E.B., Tarasova N.V., Sokolova M.V., Gorshenin A.V. The level of soluble IL-2 receptor in adults with chronic rhinosinusitis. Astrakhan medical journal. 2025;20(4):51-57. (In Russ.) https://doi.org/10.17021/1992-6499-2025-4-51-57


















